#INJ Date: 10.7 Mid- to long-term trade follow-up Ticker:

Post

#INJ Date: 10.7 Mid- to long-term trade follow-up

Ticker: INJ

Update: We recommended entering at 7.5 on the 5th. The price was rising nicely, reaching 8.3 along the way, for a gain of around 10%. Then today’s conference triggered a sharp drop, bringing it back to just above the entry price.

This pullback was mainly driven by broader market sentiment, not by any problems with the project itself. As a blockchain built specifically for finance, INJ’s medium- to long-term narratives—including RWA, institutional adoption, and its deflationary mechanism—remain intact. The technical structure has also held up.

The price has now returned to around our cost basis, improving its risk-reward profile again. You can continue holding and patiently wait for the next recovery.

币富日记

#INJ Date: 10.5 Medium- to long-term play

Ticker: INJ

Recommended entry prices: 7.5 (5 tranches), 9.5 (3 tranches), 12 (2 tranches), for an average entry around 9. Target: at least a 2x return.

Rationale: Injective’s CEO expects a U.S. spot INJ ETF to launch before 2027, possibly even sooner. A revised S-1 registration statement is also expected to be filed this September, showing that the application process is making progress.

INJ launched in 2022 and climbed to around 53 at its 2024 peak. After the market went through a bull-to-bear transition, it fell along with the broader market. It started rebounding from a bottom around 2.6 and has now reached 7.5. From the peak to the current price, that’s only about a 7x difference—much better than many other coins.

Now it’s also applying for a spot ETF. If approved, it’ll be like having a big brother backing it. What does the big brother do? Provide support. The price can rally, while the big brother helps hold up the bottom. A solid medium- to long-term pick!

Disclaimer: Includes third-party opinions. No advice. Binance AI may be used without guarantee. See T&Cs.

INJ-3.58%